Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
In: Journal of Nuclear Medicine May 1, 2017 vol. 58 no. supplement 1:247. © SNMMI.
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2018
- Creator
- URN
-
urn:nbn:de:bvb:20-opus-161168
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wolf, Herta
- Lapa, Constantin
- Buck, Andreas
- Lassmann, Michael
- Hänscheid, Heribert
- Universität Würzburg
Time of origin
- 2018
Other Objects (12)
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
TOC TOC TOC
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
TOC TOC TOC
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Tissue dose estimation after extravasation of 177Lu-DOTATATE
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Somatostatin receptor saturation after administration of high peptide amounts of [177Lu]Lu-HA-DOTATATE: when enough is enough
Predictive power of the post-treatment scans after the initial or first two courses of [177Lu]-DOTA-TATE
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
TOC TOC TOC
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry